R-HP210

Overview

R-HP210 acts on the NF-κB mediated tethered transrepression function ( IC 50 =3.80 μM). R-HP210 represses the LPS-induced transcription of a variety of proinflammatory genes such as IL-1β, IL-6 and COX-2 . R-HP210 does not induce the transactivation functions of Glucocorticoids (GCs).

Application

Products | Products > Disease Areas > Urogenital Cancer | Products > Disease Areas > Pancreatic Cancer | Products > Disease Areas > Digestive System Cancer | Products > Disease Areas > Depression | Products > Disease Areas > Pain | Products > Disease Areas > Digestive System Inflammation | Products > Disease Areas > Cancer | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Inflammation or Immune System Disease | Products > Disease Areas > Digestive System Disease | Products > Disease Areas > Urogenital Disease | Products > Disease Areas > Prostate Cancer | Products > Signaling Pathways > NF-κB | Products > Research Areas > Inflammation/Immunology | Products > Signaling Pathways > NF-κB

Product Information

• Catalog No.: HY-146564
• CAS No.: 3034696-14-2
• Molecular Formula: C22H19N3O2S2
• Molecular Weight: 421.54
• Purity: 98.21%
• Storage: Powder -20°C, 3 years ; In solvent -80°C, 6 months , -20°C, 1 month
• Solubility: ≥ 2.08 mg/mL (4.93 mM); Clear solution
• Availability: In-stock

Source

Original product source